H. Autorité-de-santé, Quelles définitions pour la pertinence des actes ? Haute Autorité de Santé, 2013.

D. A. Gorard, Escalating polypharmacy, QJM, vol.99, issue.11, pp.797-800, 2006.

M. H. Beers, J. G. Ouslander, I. Rollingher, D. B. Reuben, J. Brooks et al., Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA division of geriatric medicine, Arch Intern Med, vol.151, issue.9, pp.1825-1857, 1991.

P. Gallagher, P. O. Lang, A. Cherubini, E. Topinková, A. Cruz-jentoft et al., Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals, Eur J Clin Pharmacol, vol.67, issue.11, pp.1175-88, 2011.

A. Renom-guiteras, G. Meyer, P. A. Thürmann, . The, and . Eu, PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries, Eur J Clin Pharmacol, vol.71, issue.7, pp.861-75, 2015.

M. Passarelli, W. Jacob-filho, and A. Figueras, Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause, Drugs Aging, vol.22, issue.9, pp.767-77, 2005.

O. Reich, T. Rosemann, R. Rapold, E. Blozik, and O. Senn, Potentially inappropriate medication use in older patients in Swiss managed care plans: prevalence, determinants and association with hospitalization, PLoS One, vol.9, issue.8, p.105425, 2014.

M. Gosch, M. Wörtz, J. A. Nicholas, H. K. Doshi, C. Kammerlander et al., Inappropriate prescribing as a predictor for long-term mortality after hip fracture, Gerontology, vol.60, issue.2, pp.114-136, 2014.

M. Cecile, V. Seux, V. Pauly, S. Tassy, O. Reynaud-levy et al., Adverse drug events in hospitalized elderly patients in a geriatric medicine unit: study of prevalence and risk factors, Rev Med Interne, vol.30, issue.5, pp.393-400, 2009.

M. H. Beers, Explicit criteria for determining potentially inappropriate medication use by the elderly. An update, Arch Intern Med, vol.157, issue.14, pp.1531-1537, 1997.

P. Gallagher, C. Ryan, S. Byrne, J. Kennedy, O. 'mahony et al., STOPP (screening tool of older Person's prescriptions) and START (screening tool to alert doctors to right treatment). Consensus validation, Int J Clin Pharmacol Ther, vol.46, issue.2, pp.72-83, 2008.

D. O'mahony, O. 'sullivan, D. Byrne, S. O'connor, M. N. Ryan et al., STOPP/START criteria for potentially inappropriate prescribing in older people: version 2, Age Ageing, vol.44, issue.2, pp.213-221, 2015.

M. Laroche, J. Charmes, and M. L. , Potentially inappropriate medications in the elderly: a French consensus panel list, Eur J Clin Pharmacol, vol.63, issue.8, pp.725-756, 2007.

M. B. Rothberg, P. S. Pekow, F. Liu, B. Korc-grodzicki, M. J. Brennan et al., Potentially inappropriate medication use in hospitalized elders, J Hosp Med, vol.3, issue.2, pp.91-102, 2008.

F. Napolitano, M. T. Izzo, D. Giuseppe, G. Angelillo, and I. F. , Collaborative working group. Frequency of inappropriate medication prescription in hospitalized elderly patients in Italy, PLoS One, vol.8, issue.12, p.82359, 2013.

H. Autorité-de-santé, Comment améliorer la qualité et la sécurité des prescriptions de médicaments chez la personne âgée ? Saint-Denis La Plaine: Haute Autorité de Santé, 2014.

H. Autorité-de-santé, Benzodiazépine à demi-vie longue chez le sujet âgé. Saint-Denis La Plaine: Haute Autorité de Santé, p.4, 2012.

H. Autorité-de-santé, Date initiation du traitement connue pour tout psychotrope. Saint-Denis La Plaine: Haute Autorité de Santé, 2012.

H. Autorité-de-santé, Recherche chute tous les 3 mois si psychotropes. Saint-Denis La Plaine: Haute Autorité de Santé, p.4, 2012.

M. D. Cabana, C. S. Rand, N. R. Powe, A. W. Wu, M. H. Wilson et al., Why don't physicians follow clinical practice guidelines? A framework for improvement, JAMA, vol.282, issue.15, pp.1458-65, 1999.

N. Ivers, G. Jamtvedt, S. Flottorp, J. M. Young, J. Odgaard-jensen et al., Audit and feedback: effects on professional practice and healthcare outcomes, Cochrane Database Syst Rev, vol.6, p.259, 2012.

. Ministère-de-l'enseignement, . Supérieur, and . De-la-recherche, Article R1123-21 du Code de la santé publique relatif à la procédure d'avis des comités de protection des personnes -Modifié par Décret, 2007.

M. K. Murphy, N. A. Black, D. L. Lamping, C. M. Mckee, C. F. Sanderson et al., Consensus development methods, and their use in clinical guideline development, Health Technol Assess, vol.2, issue.3, pp.1-88, 1998.

E. Thiel, J. Jenn, A. Petit-monéger, S. Mosnier-thoumas, D. Kobeh et al., Optimisation de la prescription médicamenteuse en Unité de Soins Longue Durée. L'Année Gérontologique, vol.29, p.173, 2015.

H. Autorité-de-santé, Indicateurs de Pratique Clinique chez le sujet âgé (IPC PMSA), 2012.

P. Riehmann, M. Hanfler, and B. Froehlich, Interactive Sankey diagrams, IEEE Symposium on Information Visualization, pp.233-273, 2005.

A. Perer, F. Wang, and J. Hu, Mining and exploring care pathways from electronic medical records with visual analytics, J Biomed Inform, vol.56, pp.369-78, 2015.

M. Gobert and W. D'hoore, Prevalence of psychotropic drug use in nursing homes for the aged in Quebec and in the French-speaking area of Switzerland, Int J Geriatr Psychiatry, vol.20, issue.8, pp.712-733, 2005.

K. Y. Bilimoria, Facilitating quality improvement: pushing the pendulum Back toward process measures, JAMA, vol.314, issue.13, pp.1333-1337, 2015.

J. Lecadet, P. Vidal, B. Baris, N. Vallier, P. Fender et al., Médicaments psychotropes : consommation et pratiques de prescription en France métropolitaine. I. Données nationales, Rev Med Ass Maladie, vol.34, issue.2, pp.75-84, 2000.